Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
A106408-1g | 1g | In stock | $15.90 | |
A106408-5g | 5g | In stock | $61.90 | |
A106408-10g | 10g | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $110.90 | |
A106408-25g | 25g | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $190.90 |
Ca 2+ release modulator
Synonyms | MFCD00014823 | SB79870 | BORINIC ACID, B,B-DIPHENYL-, 2-AMINOETHYL ESTER | 2-Aminoethyl diphenylborinate | C14H16BNO | UNII-E4ES684O93 | 2-aminoethoxydephenylborate | STL481977 | HB1208 | 2-((Diphenylboryl)oxy)ethanamine | 2-(Diphenylboryloxy)Ethanamine | |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | Cell-permeable, allosteric inhibitor of D- myo -inositol 1,4,5-trisphosphate (IP3) -induced Ca 2+ release . Inhibits IP3-induced Ca 2+ release without affecting IP3 receptor binding. Blocks store operated Ca 2+ entry. |
Storage Temp | Store at -20°C,Argon charged |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | ACTIVATOR, CHANNEL BLOCKER, GATING INHIBITOR |
Mechanism of action | Channel blocker of TRPC1;Channel blocker of TRPC3;Channel blocker of TRPC4;Channel blocker of TRPC5;Channel blocker of TRPC6;Channel blocker of TRPC7;Channel blocker of TRPM2;Gating inhibitor of TRPM3;Activator of TRPM6;Activator of TRPM7;Channel blocker |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Product Description | 2-APB is a transient receptor potential (TRP) activator. The compound also directly blocks the mitochondrial permeability transition pore, sarco/endoplasmic reticulum Ca2+-ATPase pumps, and native store operated channels, as well as other ion channels. 2-APB does not activate the subfamily transient receptor potential vanilloids (TRPVs) TRPV4, TRPV5, and TRPV6, but can activate VR1 (TRPV1), VRL-1 (TRPV2), and TRPV3. 2-ABP was first used as an inhibitor of IP3R (inositol 1,4,5-triphosphate receptor) with the ability to permeate the membrane. 2-ABP can induce Ca2+entry without activating exocytosis. In pancreatic acinar cells 2-ABP can inhibit calcium mobilization. 2-APB is an activator of Orai3. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Pubchem Sid | 488179629 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488179629 |
IUPAC Name | 2-diphenylboranyloxyethanamine |
INCHI | InChI=1S/C14H16BNO/c16-11-12-17-15(13-7-3-1-4-8-13)14-9-5-2-6-10-14/h1-10H,11-12,16H2 |
InChi Key | BLZVCIGGICSWIG-UHFFFAOYSA-N |
Canonical SMILES | B(C1=CC=CC=C1)(C2=CC=CC=C2)OCCN |
Isomeric SMILES | B(C1=CC=CC=C1)(C2=CC=CC=C2)OCCN |
WGK Germany | 3 |
RTECS | ED6150000 |
PubChem CID | 1598 |
Molecular Weight | 225.09 |
Beilstein | 2942273 |
Reaxy-Rn | 2942273 |
PubChem CID | 1598 |
---|---|
CAS Registry No. | 524-95-8 |
Wikipedia | 2-Aminoethoxydiphenyl_borate |
ChEMBL Ligand | CHEMBL169233 |
RCSB PDB Ligand | FZ4 |
PubChem SID | 488179629 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
C2420151 | Certificate of Analysis | Mar 12, 2024 | A106408 |
C2420300 | Certificate of Analysis | Mar 12, 2024 | A106408 |
B2324099 | Certificate of Analysis | Mar 02, 2023 | A106408 |
B2207016 | Certificate of Analysis | Jan 17, 2022 | A106408 |
B2207071 | Certificate of Analysis | Jan 17, 2022 | A106408 |
B2207072 | Certificate of Analysis | Jan 17, 2022 | A106408 |
B2324105 | Certificate of Analysis | Jan 17, 2022 | A106408 |
Solubility | Soluble in Methanol |
---|---|
Sensitivity | Light and Moisture Sensitive |
Melt Point(°C) | 190-194°C |
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P337+P313:IF eye irritation persists: Get medical advice/attention. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P332+P313:IF SKIN irritation occurs: Get medical advice/attention. |
WGK Germany | 3 |
RTECS | ED6150000 |
Reaxy-Rn | 2942273 |
1. Kong Yuanyuan, Hu Xiaoli, Zhong Yingqun, Xu Ke, Wu Buling, Zheng Jianmao. (2019) Magnesium-enriched microenvironment promotes odontogenic differentiation in human dental pulp stem cells by activating ERK/BMP2/Smads signaling. Stem Cell Research & Therapy, 10 (1): (1-11). [PMID:31823825] [10.1186/s13287-019-1493-5] |
2. Luo M et al.. (2020) Sanguinarine Rapidly Relaxes Rat Airway Smooth Muscle Cells Dependent on TAS2R Signaling.. Biol Pharm Bull, 43 (7): (1027-1034). [PMID:32404582] |
1. Kamm GB et al.. (2021) A synaptic temperature sensor for body cooling.. Neuron, 109 (20): (3283-3297.e11). [PMID:34672983] |
2. Xie Q et al.. (2016) ABT737 reverses cisplatin resistance by regulating ER-mitochondria Ca2+ signal transduction in human ovarian cancer cells.. Int J Oncol, 49 (6): (2507-2519). [PMID:27748803] |
3. Tchernookova BK et al.. (2018) Activation of retinal glial (Müller) cells by extracellular ATP induces pronounced increases in extracellular H+ flux.. PLoS One, 13 (2): (e0190893). [PMID:29466379] |
4. Xu L et al.. (2018) Bcl-2 overexpression reduces cisplatin cytotoxicity by decreasing ER-mitochondrial Ca2+ signaling in SKOV3 cells.. Oncol Rep, 39 (3): (985-992). [PMID:29286126] |
5. Andriulė I et al.. (2022) Detection of TRPM6 and TRPM7 Proteins in Normal and Diseased Cardiac Atrial Tissue and Isolated Cardiomyocytes.. Int J Mol Sci, 23 (23): [PMID:36499188] |
6. Andriule I et al.. (2021) Evidence for the expression of TRPM6 and TRPM7 in cardiomyocytes from all four chamber walls of the human heart.. Sci Rep, 11 (15445). [PMID:34326388] |
7. Shen Y et al.. (2019) Fas signaling-mediated TH9 cell differentiation favors bowel inflammation and antitumor functions.. Nat Commun, 10 (2924). [PMID:31266950] |
8. Wang Y et al.. (2017) FGF2 promotes metastasis of uveal melanoma cells via store-operated calcium entry.. Onco Targets Ther, 10 (5317-5328). [PMID:29184418] |
9. Doengi M et al.. (2009) GABA uptake-dependent Ca(2+) signaling in developing olfactory bulb astrocytes.. Proc Natl Acad Sci U S A, 106 (41): (17570-5). [PMID:19805126] |
10. King CM et al.. (2020) Local Resting Ca2+ Controls the Scale of Astroglial Ca2+ Signals.. Cell Rep, 30 (10): (3466-3477.e4). [PMID:32160550] |
11. Kubota H et al.. (2014) mGluR1-mediated excitation of cerebellar GABAergic interneurons requires both G protein-dependent and Src-ERK1/2-dependent signaling pathways.. PLoS One, 9 (9): (e106316). [PMID:25181481] |
12. Li C et al.. (2022) PINK1-Dependent Mitophagy Reduced Endothelial Hyperpermeability and Cell Migration Capacity Under Simulated Microgravity.. Front Cell Dev Biol, 10 (896014). [PMID:35874841] |
13. Bai D et al.. (2020) Porcine deltacoronavirus (PDCoV) modulates calcium influx to favor viral replication.. Virology, 539 (38-48). [PMID:31670218] |
14. Heeley N et al.. (2018) Rapid sensing of l-leucine by human and murine hypothalamic neurons: Neurochemical and mechanistic insights.. Mol Metab, 10 (14-27). [PMID:29439854] |
15. Xie Q et al.. (2018) TAT-fused IP3R-derived peptide enhances cisplatin sensitivity of ovarian cancer cells by increasing ER Ca2+ release.. Int J Mol Med, 41 (2): (809-817). [PMID:29207009] |
16. Li L et al.. (2020) TRPM7 modulates macrophage polarization by STAT1/STAT6 pathways in RAW264.7\xa0cells.. Biochem Biophys Res Commun, 533 (4): (692-697). [PMID:33153718] |
17. Kong Yuanyuan, Hu Xiaoli, Zhong Yingqun, Xu Ke, Wu Buling, Zheng Jianmao. (2019) Magnesium-enriched microenvironment promotes odontogenic differentiation in human dental pulp stem cells by activating ERK/BMP2/Smads signaling. Stem Cell Research & Therapy, 10 (1): (1-11). [PMID:31823825] [10.1186/s13287-019-1493-5] |
18. Luo M et al.. (2020) Sanguinarine Rapidly Relaxes Rat Airway Smooth Muscle Cells Dependent on TAS2R Signaling.. Biol Pharm Bull, 43 (7): (1027-1034). [PMID:32404582] |